Sign in
4

Changes in Ownership

Raphael Pharmaceutical Inc. Filed Acc 0001213900-25-023367

Options or other derivatives

  • Director acquired 200,000 shares (grant or award)
  • Director disposed of 202,000 shares (code E)

From the SEC's structured data for this filing

Trades in this filing

Eliya Yehuda · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-03-10 Grant or award : show line 1 in the form Warrant to purchase Common Stock +200,000 200,000 D
2022-05-12 Other disposition : show line 2 in the form Warrant to purchase Common Stock −202,000 0 D
Loading xslF345X05/ownership.xml…